Equity · Healthcare
DCGO
NASDAQDocGo (DCGO)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.
- Market cap
- 59.2M USD
- Revenue, year to Dec 2025
- 322.2M USD
- EPS, diluted, year to Dec 2025
- −1.84 USD
- 52-week range
- 0.4635 USD – 1.75 USD
- Avg volume
- 143.2K
as of Jul 24, 2026
Have DocGo (DCGO) insiders bought or sold shares recently?
DCGO's newest Form 4 filing is dated 12 May 2026: none in the last 90 days.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 15 Dec 2025 | Tendler Ely DGeneral Counsel and Secretary | Sell | 16,850 | 15K USD |
13 other filings: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 12 May 2026 | Bienstock LeeChief Executive Officer | Tax withheld | 15,644 | 9K USD |
| 30 Mar 2026 | Bienstock LeeChief Executive Officer | Tax withheld | 18,811 | 11K USD |
| 15 Dec 2025 | ROSENBERG NORMANCFO and Treasurer | Tax withheld | 65,774 | 60K USD |
| 15 Dec 2025 | Sugrue StephenChief Compliance Officer | Tax withheld | 35,968 | 33K USD |
| 15 Dec 2025 | Bienstock LeeChief Executive Officer | Tax withheld | 214,131 | 195K USD |
| 12 Dec 2025 | TRAVERS JAMES M | Award | 150,000 | |
| 12 Dec 2025 | Burdiek Michael J | Award | 150,000 | |
| 12 Dec 2025 | Tendler Ely DGeneral Counsel and Secretary | Award | 100,000 | |
| 12 Dec 2025 | ROSENBERG NORMANCFO and Treasurer | Award | 429,405 | |
| 12 Dec 2025 | Leite Etalvina | Award | 150,000 | |
| 12 Dec 2025 | Smedra Ira | Award | 150,000 | |
| 12 Dec 2025 | Sugrue StephenChief Compliance Officer | Award | 321,055 |
Showing the 12 most recent of 13 compensation filings in this window. The figures above count all of them.
Which funds hold DocGo (DCGO)?
9 of the 45 institutional funds we track reported a DocGo position for the quarter ended 30 Jun 2026 — a combined 3.5M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Citadel Advisors | Held (±25%) | 2,353,610 | 1.2M USD | −5.9% |
| Renaissance Technologies | Added | 2,254,370 | 1.2M USD | +49.3% |
| AQR Capital Management | Added | 1,708,962 | 882K USD | +132.4% |
| Two Sigma Investments | New position | 343,711 | 177K USD | |
| Point72 Asset Management | New position | 41,421 | 21K USD | |
| D. E. Shaw & Co. | Held (±25%) | 30,017 | 15K USD | |
| Tudor Investment Corp | Held (±25%) | 22,329 | 12K USD | |
| Millennium Management | New position | 19,565 | 10K USD | |
| Balyasny Asset Management | New position | 13,375 | 7K USD | |
| Marshall Wace | Exited |
What has been filed or recorded for DocGo (DCGO)?
The filings we hold for DocGo, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.17 USD | Revenue $73M |
| 30 Sep 2026 | Financials | Total assets | 173.9M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 105.1M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.16 USD | Revenue $73M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.15 USD | Revenue $76M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −1.84 USD | Revenue $322M |
| 31 Dec 2025 | Financials | Revenue | 322.2M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −182.4M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −1.84 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.28 USD | Revenue $71M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.11 USD | Revenue $80M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.09 USD | Revenue $96M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 0.18 USD | Revenue $617M |
What do people ask about DocGo (DCGO)?
What is DocGo’s market cap?59.2M
DocGo is worth 59.2M USD by market value as of 24 Jul 2026, which is the share price times the shares on issue from its SEC filings.
What is DocGo’s revenue?322.2M
DocGo reported revenue of 322.2M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have DocGo insiders bought or sold shares recently?
No DocGo insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 12 May 2026 (SEC Form 4). See Insiders
Which funds own DocGo?9 of 45
9 of the 45 funds we track reported a DocGo position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Citadel Advisors, Renaissance Technologies and AQR Capital Management. See Funds
When did DocGo last report earnings?−0.17
DocGo last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.17 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings